Found: 9
Select item for more details and to access through your institution.
Durable Control of Autoimmune Diabetes in Mice Achieved by Intraperitoneal Transplantation of 'Neo-Islets,' Three-Dimensional Aggregates of Allogeneic Islet and 'Mesenchymal Stem Cells'.
- Published in:
- Stem Cells Translational Medicine, 2017, v. 6, n. 7, p. 1631, doi. 10.1002/sctm.17-0005
- By:
- Publication type:
- Article
Significant expansion of the donor pool achieved by utilizing islets of variable quality in the production of allogeneic "Neo-Islets", 3-D organoids of Mesenchymal Stromal and islet cells, a novel immune-isolating biotherapy for Type I Diabetes.
- Published in:
- PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0290460
- By:
- Publication type:
- Article
Intraperitoneal administration of human "Neo-Islets", 3-D organoids of mesenchymal stromal and pancreatic islet cells, normalizes blood glucose levels in streptozotocin-diabetic NOD/SCID mice: Significance for clinical trials.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0259043
- By:
- Publication type:
- Article
Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using “Neo-Islets,” aggregates of adipose stem and pancreatic islet cells (INAD 012-776).
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0218688
- By:
- Publication type:
- Article
760-P: Allogeneic "Neo-Islets," Organoids Composed of Cultured Pancreatic Islet and Mesenchymal Stromal Cells from Diverse Donors, Afford a Marked Increase in the Global Availability of a Curative, Novel, Anti-Rejection-Drug-Independent Biotherapy of T1DM
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-760-P
- By:
- Publication type:
- Article
204-LB: The In Vitro Characteristics of Human Islet Cells from Diverse Donors, Coaggregated with Human Mesenchymal Stromal Cells to form "Neo-islets", Are Consistently Identical: Relevance to Clinical Trials in Diabetic Subjects.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-204-LB
- By:
- Publication type:
- Article
203-LB: Redosing of Suboptimally Controlled Diabetic Mice with Human Neo-islets, 3D Aggregates of Mesenchymal Stromal and Pancreatic Islet Cells, Durably Restores Euglycemia: Relevance to the Treatment of Diabetic Humans.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-203-LB
- By:
- Publication type:
- Article
614-P: Optimal Control of Glucose and Lipid Profiles Is Critical to the Effective "Neo-Islet" Therapy of Insulin Dependent Pet Dogs.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-614-P
- By:
- Publication type:
- Article
262-OR: INAD 012-776 Pilot Study: Allogeneic "Neo-Islets," Composed of Mesenchymal Stem and Islet Cells, Are Immune Protected and Dose-Dependently and Durably Control Autoimmune T1DM in Pet Dogs.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-262-OR
- By:
- Publication type:
- Article